Hospital
San Gorgonio Memorial Hospital
San Gorgonio Memorial Hospital was paid $25.30M by Medicaid between Jan 2018 and Nov 2024, across 221 billing codes. Its largest line is 0450, Emergency room services — 15% of everything it billed.
33Billing provider infoSAN GORGONIO MEMORIAL HOSPITAL
BANNING, CA 92220
BANNING, CA 92220
33aNPI1568469997assigned 06/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.30M
24GClaims819,956
24DCodes billed221
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#105 of 410
Median peer was paid$6.90M
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 116,774 | $2.86M | |
| 2019 | 132,161 | $3.30M | |
| 2020 | 91,312 | $2.32M | |
| 2021 | 100,853 | $3.12M | |
| 2022 | 123,299 | $4.45M | |
| 2023 | 132,316 | $4.76M | |
| 2024incomplete | 123,241 | $4.48M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 15% | 74,219 | 64,103 | $3.76M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 45,239 | 40,220 | $2.84M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.0% | 4,803 | 4,695 | $1.77M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.9% | 6,952 | 6,723 | $1.49M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 19,887 | 18,409 | $1.31M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.1% | 8,026 | 7,738 | $1.29M |
| 80053 | Comprehensive metabolic panel | 2.9% | 39,271 | 34,596 | $731K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.9% | 23,062 | 21,123 | $723K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 44,568 | 38,450 | $590K |
| 93976 | 2.3% | 2,890 | 2,781 | $573K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 13,400 | 12,397 | $503K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.9% | 6,652 | 6,014 | $477K |
209 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 4,157 | $434K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.7% | 1,979 | $428K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 5,296 | $415K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 13,668 | $372K |
| Z7502 | 1.3% | 8,998 | $333K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 4,907 | $265K |
| 99285 | Emergency room visit (most serious) | 1.0% | 1,719 | $257K |
| 99070 | <1% | 48,749 | $246K | |
| 84484 | <1% | 13,358 | $239K | |
| 71045 | Radiologic examination, chest; single view | <1% | 19,652 | $233K |
| 82553 | <1% | 12,444 | $212K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,860 | $212K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,196 | $210K |
| 83690 | <1% | 16,089 | $187K | |
| 99499 | <1% | 3,001 | $173K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,953 | $169K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,384 | $158K |
| 99284 | Emergency room visit (serious) | <1% | 1,747 | $156K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,764 | $154K |
| 0762 | <1% | 2,551 | $149K | |
| 81001 | <1% | 24,135 | $145K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,472 | $140K |
| 87088 | <1% | 16,146 | $133K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 10,217 | $131K |
| 83880 | <1% | 4,961 | $124K | |
| 87076 | <1% | 4,365 | $124K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,866 | $120K |
| J3490 | Unclassified drugs | <1% | 25,694 | $116K |
| 93971 | <1% | 857 | $109K | |
| G0378 | Hospital observation service, per hour | <1% | 1,828 | $107K |
| 81025 | <1% | 13,089 | $104K | |
| 85730 | <1% | 11,708 | $104K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,105 | $102K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,211 | $100K |
| 82550 | <1% | 9,642 | $91K | |
| 83605 | <1% | 4,566 | $82K | |
| 84703 | <1% | 6,080 | $80K | |
| 87040 | <1% | 4,628 | $79K | |
| 87186 | <1% | 4,848 | $79K | |
| 85610 | <1% | 12,063 | $70K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,370 | $66K |
| 90715 | <1% | 1,931 | $65K | |
| 76801 | <1% | 1,042 | $63K | |
| 72100 | <1% | 2,038 | $60K | |
| 73030 | <1% | 2,219 | $59K | |
| 70486 | <1% | 321 | $58K | |
| 73562 | <1% | 2,417 | $56K | |
| 73610 | <1% | 2,042 | $54K | |
| 87430 | <1% | 2,943 | $53K | |
| 73130 | <1% | 1,967 | $52K | |
| 84702 | <1% | 2,637 | $50K | |
| 73630 | <1% | 2,012 | $49K | |
| 84145 | <1% | 2,436 | $48K | |
| 72131 | <1% | 257 | $46K | |
| 0710 | <1% | 1,122 | $42K | |
| 82962 | <1% | 6,521 | $40K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 774 | $39K |
| 73110 | <1% | 1,376 | $37K | |
| 83735 | <1% | 3,654 | $37K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 2,967 | $36K |
| 80305 | <1% | 2,961 | $34K | |
| Z7610 | <1% | 2,357 | $34K | |
| 82803 | <1% | 974 | $33K | |
| 85379 | <1% | 2,008 | $33K | |
| 59025 | Fetal non-stress test | <1% | 1,222 | $32K |
| 80047 | <1% | 4,136 | $31K | |
| 87335 | <1% | 2,272 | $30K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 383 | $30K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16,419 | $29K |
| 81002 | <1% | 6,493 | $27K | |
| 84481 | <1% | 1,151 | $27K | |
| 84439 | <1% | 1,657 | $26K | |
| 87070 | <1% | 1,933 | $25K | |
| 74018 | <1% | 1,135 | $22K | |
| 70496 | <1% | 118 | $21K | |
| 93970 | <1% | 95 | $19K | |
| 0370 | <1% | 121 | $19K | |
| 86901 | <1% | 2,391 | $16K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 7,463 | $16K |
| 84100 | <1% | 2,678 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 426 | $16K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 745 | $16K |
| 72040 | <1% | 568 | $14K | |
| 70498 | <1% | 131 | $14K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,570 | $14K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 11,775 | $14K |
| 73080 | <1% | 496 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 827 | $13K |
| 99221 | <1% | 67 | $13K | |
| 73590 | <1% | 618 | $13K | |
| 73090 | <1% | 599 | $12K | |
| 96367 | <1% | 281 | $12K | |
| 0270 | <1% | 451 | $12K | |
| 86900 | <1% | 2,012 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,347 | $11K |
| 71250 | <1% | 50 | $11K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 301 | $10K |
| 12001 | <1% | 601 | $10K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,832 | $10K |
| 82010 | <1% | 705 | $10K | |
| 86140 | <1% | 1,274 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,961 | $10K |
| 72070 | <1% | 332 | $10K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 217 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,871 | $10K |
| 73620 | <1% | 519 | $10K | |
| 82140 | <1% | 480 | $9K | |
| 86850 | <1% | 712 | $9K | |
| 71101 | <1% | 193 | $8K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 62 | $8K |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 25 | $8K |
| 87652 | <1% | 485 | $7K | |
| 87210 | <1% | 862 | $7K | |
| 73502 | <1% | 250 | $7K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,053 | $7K |
| 85651 | <1% | 1,274 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,548 | $6K |
| 76770 | <1% | 92 | $6K | |
| 87400 | <1% | 1,102 | $6K | |
| 87075 | <1% | 313 | $6K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 384 | $6K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 335 | $6K |
| 73560 | <1% | 295 | $6K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 816 | $6K |
| 73600 | <1% | 273 | $6K | |
| 76870 | <1% | 91 | $6K | |
| 73120 | <1% | 298 | $5K | |
| 73140 | <1% | 320 | $5K | |
| 0259 | <1% | 2,107 | $5K | |
| 86904 | <1% | 672 | $5K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 108 | $5K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,015 | $5K |
| 80061 | Lipid panel | <1% | 250 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 172 | $4K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,874 | $4K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,523 | $4K |
| 82728 | <1% | 192 | $3K | |
| 81015 | <1% | 851 | $3K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 803 | $3K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 254 | $3K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 39 | $3K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,161 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,067 | $3K |
| 70491 | <1% | 13 | $3K | |
| 99219 | <1% | 26 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,170 | $2K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,705 | $2K |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 342 | $2K |
| 87420 | <1% | 124 | $2K | |
| 96376 | <1% | 144 | $2K | |
| 99217 | <1% | 65 | $2K | |
| 10060 | <1% | 107 | $2K | |
| 72128 | <1% | 12 | $2K | |
| 29125 | <1% | 215 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 112 | $2K |
| 83615 | <1% | 201 | $2K | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 547 | $1K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 311 | $1K |
| 82947 | <1% | 284 | $1K | |
| 96368 | <1% | 56 | $1K | |
| 74022 | <1% | 31 | $1K | |
| 87449 | <1% | 116 | $1K | |
| Z9725 | <1% | 33 | $1K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 565 | $1K |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 169 | $1K |
| 76641 | <1% | 14 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,725 | $1K |
| 12011 | <1% | 55 | $1K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,568 | $987.24 |
| 12002 | <1% | 12 | $963.09 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 482 | $921.07 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 260 | $916.62 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 167 | $826.47 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 300 | $792.63 |
| 94760 | <1% | 153 | $742.71 | |
| 72170 | <1% | 46 | $710.06 | |
| 97116 | <1% | 68 | $686.87 | |
| 71020 | <1% | 28 | $674.19 | |
| J1815 | Injection, insulin, per 5 units | <1% | 80 | $656.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 112 | $522.35 |
| 29515 | <1% | 71 | $478.97 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | <1% | 28 | $463.34 |
| 73100 | <1% | 26 | $463.32 | |
| 84597 | <1% | 20 | $436.80 | |
| 82247 | <1% | 62 | $434.11 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 105 | $425.99 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 63 | $399.77 |
| 0258 | <1% | 229 | $340.35 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 113 | $302.31 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 837 | $280.00 |
| 73060 | <1% | 14 | $254.73 | |
| 73070 | <1% | 13 | $241.68 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 21 | $225.47 |
| 85007 | <1% | 69 | $205.21 | |
| 87185 | <1% | 107 | $162.21 | |
| 87592 | <1% | 13 | $153.60 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 72 | $133.10 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 46 | $122.52 |
| 87147 | <1% | 26 | $120.45 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 53 | $84.88 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 167 | $76.25 |
| J2300 | Injection, nalbuphine hydrochloride, per 10 mg | <1% | 21 | $58.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 75 | $44.90 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 253 | $30.45 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 26 | $25.30 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 18 | $1.53 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 85 | $0.00 |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 27 | $0.00 |
| 0250 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWN, MAYDA (DIRECTOR PT. FIN. SVC.)